vs
DOMO, INC.（DOMO）与Tarsus Pharmaceuticals, Inc.（TARS）财务数据对比。点击上方公司名可切换其他公司
Tarsus Pharmaceuticals, Inc.的季度营收约是DOMO, INC.的1.9倍（$151.7M vs $79.4M），Tarsus Pharmaceuticals, Inc.净利率更高（-5.5% vs -13.1%，领先7.6%），Tarsus Pharmaceuticals, Inc.同比增速更快（128.4% vs -0.5%），Tarsus Pharmaceuticals, Inc.自由现金流更多（$13.0M vs $1.1M），过去两年Tarsus Pharmaceuticals, Inc.的营收复合增速更高（134.4% vs -0.5%）
Domo股份有限公司是总部设在美国犹他州美国福克的美国云软件企业，主营人工智能、商业智能与数据可视化业务，属于SaaS（软件即服务）企业，核心产品可帮助企业各层级决策者在极少IT介入的情况下，实时获取业务数据，支撑决策开展。
Tarsus Pharmaceuticals是一家处于后期临床阶段的生物制药公司，专注于眼科、皮肤科等专科领域创新疗法的研发和商业化，主打产品针对蠕形螨睑缘炎、玫瑰痤疮等未被充分诊断的常见病症，核心市场为美国。
DOMO vs TARS — 直观对比
营收规模更大
TARS
是对方的1.9倍
$79.4M
营收增速更快
TARS
高出128.8%
-0.5%
净利率更高
TARS
高出7.6%
-13.1%
自由现金流更多
TARS
多$11.9M
$1.1M
两年增速更快
TARS
近两年复合增速
-0.5%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $79.4M | $151.7M |
| 净利润 | $-10.4M | $-8.4M |
| 毛利率 | 74.2% | — |
| 营业利润率 | -8.7% | -5.3% |
| 净利率 | -13.1% | -5.5% |
| 营收同比 | -0.5% | 128.4% |
| 净利润同比 | 44.6% | 63.8% |
| 每股收益（稀释后） | $-0.25 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOMOTARS
| Q4 25 | $79.4M | $151.7M | ||
| Q3 25 | $79.7M | $118.7M | ||
| Q2 25 | $80.1M | $102.7M | ||
| Q1 25 | $78.8M | $78.3M | ||
| Q4 24 | $79.8M | $66.4M | ||
| Q3 24 | $78.4M | $48.1M | ||
| Q2 24 | $80.1M | $40.8M | ||
| Q1 24 | $80.2M | $27.6M |
净利润DOMOTARS
| Q4 25 | $-10.4M | $-8.4M | ||
| Q3 25 | $-22.9M | $-12.6M | ||
| Q2 25 | $-18.1M | $-20.3M | ||
| Q1 25 | $-17.7M | $-25.1M | ||
| Q4 24 | $-18.8M | $-23.1M | ||
| Q3 24 | $-19.5M | $-23.4M | ||
| Q2 24 | $-26.0M | $-33.3M | ||
| Q1 24 | $-18.7M | $-35.7M |
毛利率DOMOTARS
| Q4 25 | 74.2% | — | ||
| Q3 25 | 74.8% | — | ||
| Q2 25 | 74.2% | — | ||
| Q1 25 | 74.4% | — | ||
| Q4 24 | 75.0% | — | ||
| Q3 24 | 74.3% | — | ||
| Q2 24 | 74.1% | — | ||
| Q1 24 | 76.3% | — |
营业利润率DOMOTARS
| Q4 25 | -8.7% | -5.3% | ||
| Q3 25 | -9.1% | -12.2% | ||
| Q2 25 | -17.9% | -21.6% | ||
| Q1 25 | -15.6% | -33.5% | ||
| Q4 24 | -13.9% | -36.8% | ||
| Q3 24 | -18.5% | -52.3% | ||
| Q2 24 | -26.8% | -81.6% | ||
| Q1 24 | -16.6% | -136.5% |
净利率DOMOTARS
| Q4 25 | -13.1% | -5.5% | ||
| Q3 25 | -28.8% | -10.6% | ||
| Q2 25 | -22.5% | -19.8% | ||
| Q1 25 | -22.4% | -32.1% | ||
| Q4 24 | -23.5% | -34.8% | ||
| Q3 24 | -24.9% | -48.7% | ||
| Q2 24 | -32.5% | -81.6% | ||
| Q1 24 | -23.3% | -129.4% |
每股收益（稀释后）DOMOTARS
| Q4 25 | $-0.25 | $-0.17 | ||
| Q3 25 | $-0.56 | $-0.30 | ||
| Q2 25 | $-0.45 | $-0.48 | ||
| Q1 25 | $-0.45 | $-0.64 | ||
| Q4 24 | $-0.48 | $-0.57 | ||
| Q3 24 | $-0.51 | $-0.61 | ||
| Q2 24 | $-0.69 | $-0.88 | ||
| Q1 24 | $-0.51 | $-1.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $417.3M |
| 总债务越低越好 | $124.2M | $72.4M |
| 股东权益账面价值 | $-191.9M | $343.4M |
| 总资产 | $201.6M | $562.2M |
| 负债/权益比越低杠杆越低 | — | 0.21× |
8季度趋势，按日历期对齐
现金及短期投资DOMOTARS
| Q4 25 | — | $417.3M | ||
| Q3 25 | — | $401.8M | ||
| Q2 25 | $47.2M | $381.1M | ||
| Q1 25 | $45.3M | $407.9M | ||
| Q4 24 | — | $291.4M | ||
| Q3 24 | — | $317.0M | ||
| Q2 24 | $61.2M | $323.6M | ||
| Q1 24 | $60.9M | $298.5M |
总债务DOMOTARS
| Q4 25 | $124.2M | $72.4M | ||
| Q3 25 | $121.9M | $72.3M | ||
| Q2 25 | $119.7M | $72.1M | ||
| Q1 25 | $117.7M | $72.0M | ||
| Q4 24 | $115.6M | $71.8M | ||
| Q3 24 | $115.2M | $71.7M | ||
| Q2 24 | $114.1M | $71.6M | ||
| Q1 24 | $113.5M | $29.9M |
股东权益DOMOTARS
| Q4 25 | $-191.9M | $343.4M | ||
| Q3 25 | $-191.5M | $335.1M | ||
| Q2 25 | $-178.7M | $332.6M | ||
| Q1 25 | $-177.2M | $342.5M | ||
| Q4 24 | $-171.2M | $224.5M | ||
| Q3 24 | $-166.4M | $237.5M | ||
| Q2 24 | $-163.5M | $252.2M | ||
| Q1 24 | $-153.5M | $275.2M |
总资产DOMOTARS
| Q4 25 | $201.6M | $562.2M | ||
| Q3 25 | $195.7M | $534.6M | ||
| Q2 25 | $189.7M | $495.0M | ||
| Q1 25 | $214.3M | $500.8M | ||
| Q4 24 | $190.2M | $377.0M | ||
| Q3 24 | $197.8M | $376.3M | ||
| Q2 24 | $204.4M | $376.8M | ||
| Q1 24 | $225.7M | $349.3M |
负债/权益比DOMOTARS
| Q4 25 | — | 0.21× | ||
| Q3 25 | — | 0.22× | ||
| Q2 25 | — | 0.22× | ||
| Q1 25 | — | 0.21× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.30× | ||
| Q2 24 | — | 0.28× | ||
| Q1 24 | — | 0.11× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.4M | $19.3M |
| 自由现金流经营现金流 - 资本支出 | $1.1M | $13.0M |
| 自由现金流率自由现金流/营收 | 1.4% | 8.6% |
| 资本支出强度资本支出/营收 | 2.9% | 4.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $9.9M | $-22.3M |
8季度趋势，按日历期对齐
经营现金流DOMOTARS
| Q4 25 | $3.4M | $19.3M | ||
| Q3 25 | $3.4M | $18.3M | ||
| Q2 25 | $4.0M | $-29.4M | ||
| Q1 25 | $8.9M | $-20.7M | ||
| Q4 24 | $-13.7M | $-22.2M | ||
| Q3 24 | $-6.2M | $-8.7M | ||
| Q2 24 | $1.9M | $-14.4M | ||
| Q1 24 | $5.4M | $-37.8M |
自由现金流DOMOTARS
| Q4 25 | $1.1M | $13.0M | ||
| Q3 25 | $1.0M | $16.3M | ||
| Q2 25 | $1.0M | $-30.4M | ||
| Q1 25 | $6.7M | $-21.2M | ||
| Q4 24 | $-16.2M | $-22.3M | ||
| Q3 24 | $-8.4M | $-8.9M | ||
| Q2 24 | $-625.0K | $-15.4M | ||
| Q1 24 | $2.9M | $-38.0M |
自由现金流率DOMOTARS
| Q4 25 | 1.4% | 8.6% | ||
| Q3 25 | 1.3% | 13.8% | ||
| Q2 25 | 1.3% | -29.6% | ||
| Q1 25 | 8.5% | -27.1% | ||
| Q4 24 | -20.3% | -33.5% | ||
| Q3 24 | -10.7% | -18.6% | ||
| Q2 24 | -0.8% | -37.8% | ||
| Q1 24 | 3.6% | -137.5% |
资本支出强度DOMOTARS
| Q4 25 | 2.9% | 4.2% | ||
| Q3 25 | 2.9% | 1.6% | ||
| Q2 25 | 3.7% | 1.0% | ||
| Q1 25 | 2.8% | 0.8% | ||
| Q4 24 | 3.2% | 0.1% | ||
| Q3 24 | 2.8% | 0.6% | ||
| Q2 24 | 3.2% | 2.5% | ||
| Q1 24 | 3.1% | 0.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOMO
| Subscription | $71.9M | 91% |
| Professional Servicesand Other | $7.5M | 9% |
TARS
暂无分部数据
